Document is current

Any future updates will be listed below

Efficacy and safety of GLP-1 receptor agonists in the treatment of type 2 diabetes and/or obesity in patients with Cushing’s syndrome: a multicenter retrospective study

Crossref DOI link: https://doi.org/10.1007/s12020-026-04587-7

Published Online: 2026-03-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark